The expanding role of nerve growth factor: From neurotrophic activity to immunologic diseases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 9, 1997, Pages 883-994

  Aloe, L ^a   Bracci Laudiero, L ^a   Bonini, S ^b   Manni, L ^a  

^a CNR   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Allergy; Autoimmune diseases; Inflammation; Lymphocytes; Mast cells; Nerve growth factor

Indexed keywords

DNA FRAGMENT; NEUROTROPHIC FACTOR;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; DOSE RESPONSE; HISTAMINE RELEASE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOCYTE DIFFERENTIATION; MAST CELL; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN CELL;

EID: 0030827687     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb01247.x     Document Type: Review

References (140)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
2. Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev 1968;48:534-69.
3. Barde YA. The nerve growth factor family. Prog Growth Factor Res 1990;2:237-48.
4. Levi-Montalcini R, Angeletti PU. Immunosympathectomy. Pharmacol Rev 1966;18:619-28.
5. Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem 1987; 109:145-78.
6. Levi-Montalcini R, Aloe L, Alleva E. A role for nerve growth factor in nervous, endocrine and immune systems. Prog Neuroendocrinimmunol 1990;3:1-10.
7. Thoenen H, Barde YA. Physiology of nerve growth factor. Physiol Rev 1980;1284-1335.
8. Pincelli C, Sevignani C, Manfredini R, et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994; 103:13-18.
9. Fantini F, Johansson O. Expression of growth-associated protein 43 and nerve growth factor receptor in human skin: a comparative immunohistochemical investigation. J Invest Dermatol 1992;99:734-42.
10. Bocchini G, Angeletti PU. The nerve growth factor: purification as a 30,000 molecular-weight protein. Proc Natl Acad Sci U S A 1996;64:787-94.
11. Hogue-Angeletti R, Bradshaw RA. Nerve growth factor from mouse submaxillary gland; amino acid sequence. Proc Natl Acad Sci U S A 1971;68:2417-20.
12. Gotz R, Schartl M. The conservation of neurotrophic factors during vertebrate evolution. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1994;108:1-10.
13. Francke U, De Martinville B, Coussen L, Ullrich A. The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1. Science 1983;222:1248-51.
14. Scott J, Selby M, Urdea M, Quiroga M, Bell GI, Rutter WJ. Isolation of nucleotide of a cDNA encoding the precursor of mouse nerve growth factor. Nature 1983;302: 538-40.
15. Aloe L, Alleva E, Böhm A, Levi-Montalcini R. Aggressive behaviour induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci U S A 1986;83:6184-7.
16. Alleva E, Aloe L, Bigi S. An update role for nerve growth factor in neurobehavioural regulation of adult vertebrates. Rev Neurosci 1993;4:41-63.
17. Aloe L, Alleva E, De Simone R. Changes of NGF level in mouse hypothalamus following intermale aggressive behavior: biological and immunohistochemical evidence. Behav Brain Res 1990;39:53-61.
18. Aloe L. The effect of nerve growth factor and its antibody on mast cells in vivo. J Neuroimmunol 1988;18:1-12.
19. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. Emotional stress induced by parachute jumping changes blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci U S A 1994;91:10440-4.
20. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358-66.
21. Aloe L, Skaper SD, Leon A, Levi-Montalcini R. Nerve growth factor and autoimmune diseases. Autoimmunity 1994;19:141-50.
22. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992;35:351-5.
23. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, et al. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-12.
24. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, et al. Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport 1993;4:563-5.
25. Bonini Se, Lambiase A, Bonini St, et al. Circulating nerve growth factor levels are increased in human with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93:10955-60.
26. Lambiase A, Bonini St, Bonini Se, et al. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci 1995;36:2127-32.
27. Friedman WJ, Lärkfors L, Ayer-LeLievre C, Ebendal T, Olson L, Persson H. Regulation of β-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J Neurosci Res 1990;27:374-82.
28. Gadient RA, Cron KC, Otten U. Interleukin-1β and tumor necrosis factor-α synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 1990;117:335-40.
29. Gasser UE, Weskamp G, Otten U, Dravid AR. Time course of the elevation of nerve growth factor (NGF) content in the hippocampus and septum following lesions of the septohippocampal pathway in rats. Brain Res 1986;376:351-6.
30. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987;330:658-9.
31. Green SH, Rydel RE, Connolly JL, Greene LA. PC12 mutants that possess low but not high-affinity nerve growth factor receptors neither respond to nor internalise nerve growth factor. J Cell Biol 1986;102:830-43.
32. Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene 1993;8:2033-42.
33. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci 1992;15:323-31.
34. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurones. Nature 1989;337:362-4.
35. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neurosci 1992;49:693-8.
36. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993;13:2136-48.
37. Snider WD, Johnson EM Jr. Neurotrophic molecules. Ann Neurol 1989;26:489-506.
38. Anand P. Nerve growth factor regulates nociception in human health and disease. Br J Anaesth 1995;75:201-8.
39. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994;634: 7-12.
40. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62:327-31.
41. Korsching S. The role of NGF in the CNS. Trends Neurosci 1986;9:570-3.
42. Whittemore SR, Seiger A. The expression, localization and functional significance of β-nerve growth factor in the central nervous system. Brain Res 1987;12:439-64.
43. Cimino M, Cattabeni F, Di Luca M, et al. Levels of NGF, p75 NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats. Neurobiol Aging 1996;17: 137-42.
44. Fisher W, Wiktorin K, Björklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987;329:65-8.
45. Chen KS, Gage FH. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J Neurosci 1995;15:2819-25.
46. Whittemore SR, Holets VR, Keane RW, Levy DJ, McKay RD. Transplantation of a temperature-sensitive, nerve growth factor-secreting, neuroblastoma cell line into adult rats with fimbria-fornix transection lesion rescues cholinergic septal neurons. J Neurosci Res 1991;28:156-70.
47. Liberini P, Cuello AC. Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical Neurology 1994;5:89-104.
48. Scott SA, Crutcher KA. Nerve growth factor and Alzheimer's disease. Rev Neurosci 1994;5:179-211.
49. Eide FF, Løwenstein DH, Reichardt LF. Neurotrophins and their receptors - current concepts and implications for neurologic disease. Exp Neurol 1993;121:200-14.
50. Holtzman DM, Li Y, Chen K, Gage FH, Epstein CJ, Mobley WC. Nerve growth factor reverses neuronal atrophy in a Down's syndrome model of age-related neurodegeneration. Neurology 1993;43:2668-73.
51. Coyle JT, Price DL, De Long MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219:1184-90.
52. Friden PM, Walus LR, Watson P, et al. Blood-brain barrier penetration and in vivo activity of NGF conjugate. Science 1993;259:373-5.
53. Saita K, Ohi T, Hanaoka Y, et al. Effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental acrylamide-induced neuropathy in rats. Neurotoxicology 1995;16:403-12.
54. Spillantini MG, Aloe L, Alleva E, De Simone R, Goedert M, Levi-Montalcini R. Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Proc Natl Acad Sci U S A 1989;86:8555-9.
55. Otten U, Baumann JB, Girard J. Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 1979;282:413-14.
56. Lahtinen T, Soinila S, Lakshmanan J. Biological demonstration of nerve growth factor in the rat pituitary gland. Neuroscience 1989;30:165-70.
57. Ojeda SR, Hill DF, Katz KH. The genes encoding nerve growth factor and its receptor are expressed in the developing female rat hypothalamus. Mol Brain Res 1991;9:47-55.
58. Dicou E, Lee J, Brachet P. Synthesis of nerve growth factor mRNA and precursor protein in the thyroidcand parathyroid glands of the rat. Proc Natl Acad Sci USA 1986;83:7084-8.
59. Aloe L. Adrenalectomy decreases nerve growth factor in young adult rat hippocampus. Proc Natl Acad Sci USA 1989;86:5636-40.
60. Aloe L, Cozzari C, Calissano P, Levi-Montalcini R. Somatic and behavioral postnatal effects of fetal injections of nerve growth factor antibodies in the rat. Nature 1981;291:413-15.
61. Johnson EM Jr, Osborne PA, Rydel RE, Schmidt RE, Pearson J. Characterization of the effects of autoimmune nerve growth factor deprivation in the developing guinea pig. Neuroscience 1983;8:631-42.
62. Beutler B, Huffel C. Unraveling function in the TNF ligand and receptor families. Science 1994;264:667-8.
63. Kaplan DR, Martin-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk protooncogene product induced by NGF. Nature 1991; 350:150-60.
64. Martin-Zanca DR, Oskan R, Mitra G, Copeland T, Barbacid M. Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 1989;9: 24-33.
65. Chao MV, Hempstead BL. p75 and trk: a two receptor system. Trends Neurosci 1995;18:321-6.
66. Thorpe LW, Stach RW, Hashim GA, Marchetti D, Perez-Polo JR. Receptors for nerve growth factor on rat spleen mononuclear cells. J Neurosci Res 1987;17:128-34.
67. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A 1993;90:10984-8.
68. Ehrhard PB, Ganter U, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci U S A 1993;90:5423-7.
69. Melamed I, Kelleher CA, Franklin RA, et al. Nerve growth factor signal transduction in human B lymphocyte is mediated by gp140 trk. Eur J Immunol 1996;26:1885-1992.
70. Horigome K, Pryor JC, Bullock ED, Johnson EM Jr. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 1993;268:14881-7.
71. Aloe L, De Simone R. NGF primed spleen cells injected in brain of developing rats differentiate into mast cells. Int J Dev Neurosci 1989;7:565-73.
72. Kawamoto K, Okada T, Kannan Y, Ushio H, Matsumoto M, Matsuda H. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood 1995;86:4638-44.
73. Jippo T, Ushio H, Hirota S, et al. Poor response of cultured mast cells derived from mi/mi mutant mice to nerve growth factor. Blood 1994;84:2977-83.
74. Bruni A, Bigon E, Boarato E, Mietto L, Leon A, Toffano G. Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett 1982; 138:190-2.
75. Horigome K, Bullock ED, Johnson EM Jr. Effects of nerve growth factor on rat peritoneal mast cells. J Biol Chem 1994;269:2695-2702.
76. Bracci-Laudiero L, Vigneti E, Aloe L. In vivo and in vitro effect of NGF on bursa of Fabricius cells during chick embryo development. Int J Neurosci 1991;59:189-98.
77. Bracci-Laudiero L, Vigneti E, Iannicola C, Aloe L. NGF retards apoptosis in chick embryo bursal cell in vitro. Differentiation 1993;53:61-6.
78. Auffray I, Chevalier S, Froger J, et al. Nerve growth factor is involved in the supportive effect by bone marrow derived stromal cells of the factor-dependent human cell line UT-7. Blood 1996;88:1608-18.
79. Hamada A, Watanabe N, Ohtomo H, Matsuda H. Nerve growth factor enhances survival and cytotoxic activity of human eosinophils. Br J Haematol 1996;93:299-302.
80. Kannan Y, Ushio H, Koyama H, et al. Nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 1991;77:1320-5.
81. Kannan Y, Usami K, Okada M, Shimizu S, Matsuda H. Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem Biophys Res Commun 1992;186:1050-6.
82. Torcia M, Bracci-Laudiero L, Lucibello M, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996;85:345-56.
83. Matsuda H, Coughlin MD, Bienenstock J, Denburg JA. Nerve growth factor promotes human hemapoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988;85:6508-12.
84. Kannan Y, Matsuda H, Ushio H, Kawamoto K, Shimada Y. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int Arch Allergy Immunol 1993;102:362-7.
85. Tsuda T, Wong D, Dolovich J, Bienenstock J, Marshall J, Denburg JA. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 1991;77: 971-9.
86. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992;79:2662-9.
87. 4 production by human eosinophils triggered with N-formyl-methionyl-leuylphenylalanine. Eur J Immunol 1992;22:969-74.
88. Gee AP, Boyle MDP, Munger KL, Lawman MJP, Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A 1983;80:7215-18.
89. Boyle MDP, Lawman MJP, Gee AP, Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 1985;134:564-8.
90. Thorpe LW, Perez-Polo JR. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res 1987;18:134-9.
91. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A 1989;86:10059-63.
92. Kimata H, Yoshida A, Ishioka C, Kusunoki T, Hosoi S, Mikawa H. Nerve growth factor specifically induces human lgG4 production. Eur J Immunol 1991;21:137-41.
93. Brodie C, Gelfand EW. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol 1992;148:3492-7.
94. Brodie C, Oshiba A, Renz H, Bradley K, Gelfand EW. Nerve growth factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes. Eur J Immunol 1996;26:171-8.
95. Thorpe LW, Werrbach-Perez K, Perez-Polo JR. Effects of nerve growth factor expression on interleukin-2 receptors on cultured human lymphocytes. Ann N Y Acad Sci 1987; 496:310-11.
96. Pezzati P, Stanisz AM, Marshall JS, Bienenstock J, Stead RH. Expression of nerve growth factor receptor immunoreactivity on follicular dendritic cells from human mucosa associated lymphoid tissues. Immunology 1992;76: 485-90.
97. Cattoretti G, Schirò R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-38.
98. Laurenzi MA, Barbany G, Timmusk T, Lindgren JA, Persson H. Expression of mRNA encoding neurotrophins and neurotrophin receptors in rat thymus, spleen tissue and immunocompetent cells. Eur J Biochem 1994;223: 733-41.
99. Ciriaco E, Dall'Aglio C, Hannestad J, et al. Localization of trk neurotrophin receptor-like proteins in avian primary lymphoid organs: thymus and bursa of Fabricius. J Neuroimmunol 1996;69:73-83.
100. Sacerdote P, Manfredi B, Aloe L, Micera A, Panerafi AE. Centrally injected nerve growth factor modulates peripheral immune responses in the rat. Neuroendocrinology 1996;64:274-9.
101. Aloe L, Tuveri MA, Levi-Montalcini R. Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol Int 1992;12:213-16.
102. Aloe L, Probert L, Kollias G, et al. The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 1993;9:149-55.
103. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode infected intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci U S A 1987;84: 2975-9.
104. Galli SJ, Dvorak AM, Dvorak HF. Basophils and mast cells: morphologic insights into their biology, secretory patterns and function. Prog Allergy 1984;34:1-141.
105. Johnson D, Krenger W. Interactions of mast cells with the nervous system - recent advances. Neurochem Res 1992; 9:939-51.
106. Purcell WM, Atterwill CK. Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem Res 1995;20:521-32.
107. Getchell ML, Kulkarni-Narla A, Takami S, Albers KM, Getchell TV. Age-dependent phenotypic switching of mast cells in NGF-transgenic mice. Neuroreport 1995;6: 1261-6.
108. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 1991;3: 865-72.
109. Cacabelos R, Yamatodami A, Nigawa H, et al. Brain histamine in Alzheimer's disease. Methods Find Exp Clin Pharmacol 1989;11:353-60.
110. McGeer PL, Roger J, McGeer EG. Neuroimmune mechanisms in Alzheimer's disease pathogenesis. Alzheimer Dis Assoc Disord 1994;8:149-58.
111. Rogers J, Kirby LC, Hemplelman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993; 43:1609-11.
112. MacKenzie IRA. Antiinflammatory drugs in the treatment of Alzheimer's disease. J Rheumatol 1996;23:807-8.
113. Aloe L, Tuveri MA, Angelucci F. Nerve growth factor, mast cells and arthritis. Biomedical Rev 1995;4:7-114.
114. Santambrogio L, Benedetti M, Chao MV, et al. Nerve growth factor production by lymphocytes. J Immunol 1994;153:4488-92.
115. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A 1994;91:3739-43.
116. Lambiase A, Bracci-Laudiero L, Bonini Se, et al. Human CD4+ T-clones produce and release nerve growth factor and express trkA. Allergy Clin Immunol 1997 (in press).
117. Fernyhough P, Diemel LT, Hardy J, Wendy J, Mohiuddin L, Tomlison DR. Human recombinant nerve growth replaces deficient neurotrophic support in diabetic rats. Eur J Neurosci 1995;7:1107-10.
118. Petty BG, Cornblath DR, Adornato BT, et al. The effect of systemically administered recombinant nerve growth factor in healthy human subjects. Ann Neurol 1994;36: 244-6.
119. Tuveri MA, Passiu G, Mathieu A, Aloe L. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin Exp Rheumatol 1993;11: 319-22.
120. Aloe L, Moroni R, Mollinari C, Tirassa P. Schistosoma mansoni infection enhances the levels of NGF in the liver and hypothalamus. Neuroreport 1994;5:1030-2.
121. Bracci-Laudiero L, Lundegerg T, Stenfors C, Theodorson E, Tirassa P, Aloe L. Modification of lymphoid and brain nerve growth factor levels in systemic lupus erythematosus mice. Neurosci Lett 1996;204:13-16.
122. De Simone R, Micera A, Tirassa P, Aloe L. mRNA for NGF and p75 in the central nervous system of rats affected by experimental allergic encephalomyelitis. Neuropathol Appl Neurobiol 1996;22:54-9.
123. Aloe L, Tuveri M, Guerra G, et al. Changes in human plasma nerve growth factor level after chronic alcohol consumption and withdrawal. Alcohol Clin Exp Res 1996; 20:462-5.
124. Aloe L, Moroni R, Angelucci F. Evidence of a role for nerve growth factor in the effect of sialoadenectomy on body temperature of parasite-infected mice. Arch Oral Biol 1996;41:21-6.
125. Dicou E, Hurez D, Nerrière V. Natural autoantibodies against nerve growth factor in autoimmune diseases. J Neuroimmunol 1993;47:159-68.
126. Aloe L, Musi B, Micera A, Santucci D, Tirassa P, Alleva E. NGF antibody production as a result of repeated psychosocial stress in adult mice. Neurosci Res Commun 1995; 16:19-28.
127. Chevalier S, Praloran V, Smith C, et al. Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood 1994;83:1479-85.
128. Chesa PG, Rettig WJ, Thomson TM, Old LJ, Melamed MR. Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissue. J Histochem Cytochem 1998;36:383-9.
129. Simone MD, Papa G, Vigneti E, Stasi R, Aloe L. Levels of nerve growth factor and distribution of its receptor in chronic myeloproliferative disorders. 34o Congresso Ematol., Naples, 5-8 Oct 1993.
130. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger R. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastoma. J Natl Cancer Inst 1993;85: 377-84.
131. Warren KS, editor. Immunology and molecular biology of parasitic infection. 3rd ed. Boston, MA: Blackwell Scientific, 1993:1-610.
132. Duvaux-Miret O, Stefano GB, Smith EM, Dissous C, Capron A. Immunosuppression in the definitive and intermediate host of the human parasite Schistosoma mansoni by release of immunoreactive neuropeptides. Proc Natl Acad Sci U S A 1992;89:778-81.
133. Aloe L, Moroni R, Fiore M, Angelucci F. Chronic parasite infection in mice induces brain granulomas and differentially alters brain nerve growth factor levels and thermal responses in paws. Acta Neuropathol 1996;92:300-5.
134. Bonini Se, Bonini St, Lambiase A, Aloe L. Immune, endocrine and neural aspects of allergic inflammation. XVI European Congress of Allergology and Clinical Immunology. Madrid, Spain, 24-25 June 1995.
135. Goedert M, Stoeckel K, Otten U. Biological importance of the retrograde transport of nerve growth factor in sensory neurons. Proc Natl Acad Sci U S A 1981;78: 5895-8.
136. Maestripieri D, De Simone R, Aloe L, Levi-Montalcini R. Social status and nerve growth factor serum levels after agonistic encounters in mice. Physiol Behav 1990;47:161-4.
137. Alleva E, Della Seta D, Cirulli F, Aloe L. Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:483-9.
138. Aloe L, Iannitelli A, Bersani G, et al. Haloperidol administration in human lowers plasma nerve growth factor level: evidence that sedation induces opposed effect than arousal. Neuropsychobiology 1997 (in press).
139. Michel FB. Psychology of allergic patient. Allergy 1994;49 Suppl 18:28-30.
140. Chaldakov GN, Chenev PI, Valchanov K, Tonchev A, Pancheva R. Nerve-mast cell-nerve growth factor link: the mast cell as yin-yang modulator in inflammation and fibrosis. Biomed Rev 1995;4:1-6.